'Superbly edited by Denis G. Arnold, Ethics and the Business of Biomedicine combines academic rigor with up-to-date consideration of contemporary developments in the field of biomedicine. … makes an outstanding contribution to understanding the ethical implications of the deep transformations that are occurring in the financing and delivery of healthcare in the twenty-first century.' Business Ethics Quarterly
Introduction, 1. Medicine and the market Daniel Callahan; 2. Broken promises: do business friendly strategies frustrate just health care? Norman Daniels; 3. Are patents an efficient and internationally fair means of funding research and development for new medicines? Paul Menzel; 4. The exploitation of the economically disadvantaged in pharmaceutical research disclosure Tom L. Beauchamp; 5. The dangers of detailing: how pharmaceutical marketing threatens health care Jason Hubbard; 6. The ethics of direct to consumer pharmaceutical advertising Denis G. Arnold; 7. Industry-funded bioethics and the limits of disclosure Carl Elliott; 8. Two cheers for the pharmaceutical industry Richard T. De George; 9. The third face of medicine: ethics and business and challenges to professionalism Mary V. Rorty, Patricia Werhane, and Ann Mills; 10. Theoretical foundations for an organizational ethics: developing norms for a new kind of health care George Khushf; 11. A crisis in medical professionalism: time for Flexner II Daniel Wikler; Bibliography; Index.